MedWatch

Pfizer expands EU supply deals

The EU Commission has adjusted its contract with Pfizer in a bid to streamline the future supply of Covid-19 vaccine Corminaty in the region. Pfizer expects billions of euros in revenue from the jabs.

European Commissioner for Health and Food Safety Stella Kyriakides | Photo: Julien Warnand/AP/Ritzau Scanpix

BRUSSELS

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs